Free Account Opening + AMC Free Demat
Loading...

Marksans Pharma Buyback vs Suraj Limited Buyback

Comparision between Marksans Pharma Buyback and Suraj Limited Buyback.

Buyback Details

Marksans Pharma Buyback is a Open Market Through Stock Exchange buyback proposed to list at BSE, NSE while Suraj Limited Buyback is a Tender Offer proposed to list at BSE.

  Marksans Pharma Ltd Suraj Limited
Logo Marksans Pharma Buyback Logo Suraj Limited Buyback Logo
Type of Buyback Open Market Through Stock Exchange Tender Offer
Listing At BSE, NSE BSE
Face Value ₹1 per share ₹10 per share
Buyback Price ₹60 per share ₹77 per share
Issue Size 9,00,000 shares
Issue Size (Amount) ₹60.00 Crores ₹6.93 Crores
Buyback Ratio
Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 184 Equity Share out of every 813 Fully paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 37 Equity Shares out of every 663 Fully paid-up Equity Shares held on the Record Date.
Registrar Bigshare Services Pvt Ltd Bigshare Services Pvt Ltd
Lead Managers Sundae Capital Advisors Beeline Capital Advisors Pvt Ltd
Necessity of the buyback

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

The buyback is being undertaken for the following reasons:

  1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity.
  2. The Buyback is being undertaken, inter alia, for helping the Company to return surplus cash to the Eligible Shareholders broadly in proportion to their shareholding, thereby, enhancing the overall return to the Equity Shareholders.

Buyback Timetable

Marksans Pharma Buyback and Suraj Limited Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Marksans Pharma Buyback Buyback record date is . Suraj Limited Buyback Buyback record date is Aug 20, 2022.

  Marksans Pharma Ltd Suraj Limited
Record Date Aug 20, 2022
Offer Open Date Jul 15, 2022 Sep 14, 2022
Offer Closure Date Jan 14, 2023 Sep 27, 2022
Last date for receipt of tender forms Sep 27, 2022
Finalisation of buyback Oct 06, 2022
Last Date for settlment of bids Oct 07, 2022
Last Date for extinguishment of shares Oct 14, 2022

Financial Details and Other Relevent Information

Comparison of Marksans Pharma Buyback and Suraj Limited Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Marksans Pharma Ltd Suraj Limited
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakhs)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,53,269.20 1,38,287.61 1,13,453.67
Profit After Tax 18,681.40 23,853.88 12,075.27
Net Worth 1,04,216.44 86,972.58 61,990.88
Reserves and Surplus 99,623.30 82,379.44 57,397.74
Suraj Limited Financial Information (Restated)
Period EndedTotal RevenueProfit After TaxNet Worth
31-Mar-20177.031.0187.77
31-Mar-21192.381.3789.14
31-Mar-22348.76392.17
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.70 44.28
May-2022 53.45 44.50 48.20
Apr-2022 62.35 45.55 55.56

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jul-2022 76.45 62.05 69.25
Jun-2022 73.60 61.05 67.33
May-2022 80.00 63.30 71.65
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.60 44.15
May-2022 53.50 44.50 48.23
Apr-2022 62.40 45.50 56.03

Comments

Add a public comment...